Abstract
Sirtuins (SIRTs) are a class of nicotine adenine dinucleotide (NAD+)-dependent proteins which participate in numerous molecular pathways involved in various age-related human diseases, such as type II diabetes, cardiovascular (CV) diseases and cancer. They have a major role in apoptosis, inflammation, oxidative stress and metabolism regulation, traits that have a great impact on CV physiology and pathology. Their unique profile of NAD+ energy dependency makes them an appealing target for human intervention in cellular and metabolic processes. This review focuses on the recent advances of SIRTs research aiming to shed light on the emerging roles of SIRTs in the pathophysiology of CV and metabolic diseases.
Keywords: Sirtuins, aging, cardiovascular diseases, cancer, apoptosis, oxidative stress.
Graphical Abstract
Current Vascular Pharmacology
Title:The Tree of Sirtuins and the Garden of Cardiovascular Youth
Volume: 14 Issue: 1
Author(s): Vasiliki K. Katsi, Antonios N. Pavlidis, Charalampos I. Liakos, Maria E. Marketou, Leonidas G. Raftopoulos, Nikolaos A. Alexopoulos, Thomas K. Makris, Petros Nihoyannopoulos, Dimitris Tousoulis and Ioannis E. Kallikazaros
Affiliation:
Keywords: Sirtuins, aging, cardiovascular diseases, cancer, apoptosis, oxidative stress.
Abstract: Sirtuins (SIRTs) are a class of nicotine adenine dinucleotide (NAD+)-dependent proteins which participate in numerous molecular pathways involved in various age-related human diseases, such as type II diabetes, cardiovascular (CV) diseases and cancer. They have a major role in apoptosis, inflammation, oxidative stress and metabolism regulation, traits that have a great impact on CV physiology and pathology. Their unique profile of NAD+ energy dependency makes them an appealing target for human intervention in cellular and metabolic processes. This review focuses on the recent advances of SIRTs research aiming to shed light on the emerging roles of SIRTs in the pathophysiology of CV and metabolic diseases.
Export Options
About this article
Cite this article as:
Katsi K. Vasiliki, Pavlidis N. Antonios, Liakos I. Charalampos, Marketou E. Maria, Raftopoulos G. Leonidas, Alexopoulos A. Nikolaos, Makris K. Thomas, Nihoyannopoulos Petros, Tousoulis Dimitris and Kallikazaros E. Ioannis, The Tree of Sirtuins and the Garden of Cardiovascular Youth, Current Vascular Pharmacology 2016; 14 (1) . https://dx.doi.org/10.2174/1570161113666150916093902
DOI https://dx.doi.org/10.2174/1570161113666150916093902 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design mTOR in Growth and Protection of Hypertrophying Myocardium
Cardiovascular & Hematological Agents in Medicinal Chemistry New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients
Current Vascular Pharmacology Endocrine Therapies and QTc Prolongation
Current Drug Safety Resident Cardiac Stem Cells
Current Pharmaceutical Design Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine
Current Medicinal Chemistry The Role of Nitro (NO<sub>2</sub>-), Chloro (Cl), and Fluoro (F) Substitution in the Design of Antileishmanial and Antichagasic Compounds
Current Drug Targets Pearls from the First Gulf Cardiac Amyloidosis Summit 2021
New Emirates Medical Journal Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose
Current Drug Therapy Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature
Current Medical Imaging Current Concepts on Prenatal Diagnosis and Management of Fetal Tachyarrythmias
Current Cardiology Reviews Heart Failure in North America
Current Cardiology Reviews Meet Our Editorial Board Member:
Current Vascular Pharmacology microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology What is Tobacco Smoke? Sociocultural Dimensions of the Association with Cardiovascular Risk
Current Pharmaceutical Design Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases
Current Drug Targets A Palliative Care Approach to the Advanced Heart Failure Patient
Current Cardiology Reviews